PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients
Article in Inflammopharmacology (July 2023)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Article in Inflammopharmacology (July 2023)
Article in Journal of Immunological Methods (May 2023)
Article in Frontiers in Immunology (January 2023)